Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract
ABSTRACT Objective Currently, chimeric antigen receptor T‐cell (CART) therapy represents a highly effective approach for relapsed/refractory B‐cell lymphomas. However, it also carries treatment‐related risks. Limited data are available on the risks associated with CART therapy in patients with gastr...
Saved in:
Main Authors: | Lixia Ma, Yimeng Dou, Rui Liu, Teng Xu, Fan Yang, Peihao Zheng, Shaomei Feng, Yuelu Guo, Hui Shi, Fei Xue, Biping Deng, Xiaoyan Ke, Kai Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.70083 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synchronous clonally related anaplastic large cell lymphoma and malignant histiocytosis
by: Mirvate Harb, et al.
Published: (2025-01-01) -
Primary giant ovarian diffuse large B-cell lymphoma
by: Maoyu Zhang, et al.
Published: (2025-02-01) -
Effect of comorbidity classes on survival of patients with gastrointestinal tract cancer
by: Linna Gao, et al.
Published: (2025-02-01) -
Anti-nuclear matrix protein 2 antibody-associated juvenile dermatomyositis with gastrointestinal perforations was successfully treated with traditional therapeutic drugs combined with vedolizumab: a case report after a long-term follow-up and a review of the literature
by: Xue-mei Xu, et al.
Published: (2025-01-01) -
Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
by: Tomohiro Kadota, et al.
Published: (2019-03-01)